Claritas Pharmaceuticals (KALTF) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free KALTF Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartStock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDPHAY - Dechra Pharmaceuticals PLCfinance.yahoo.com - July 6 at 11:29 PMAnimal Health Active Pharmaceutical Ingredients Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2030marketwatch.com - June 22 at 2:49 PMACXP - Acurx Pharmaceuticals, Inc.finance.yahoo.com - June 21 at 6:11 PMPharmaceutical Lecithin Market Size, Growth, Outlook, Share, Segmentation Analysis, Revenue And Forecast 2031marketwatch.com - April 27 at 11:59 PMGeneric Drugs Market Share, Segmentation and Forecast 2023-2028marketwatch.com - March 17 at 5:48 PM2023 Pharmaceutical CDMO Services Market Segmentation and Targeting: Strategies for Success Forecast till 2028marketwatch.com - February 14 at 9:16 AM2023 Mifepristone Market Segmentation and Targeting: Strategies for Success Forecast till 2028marketwatch.com - February 13 at 2:37 PMRadioimmunotherapy Treatment Market Geographical Segmentation By Forecast Revenue 2023-2028marketwatch.com - January 19 at 9:22 AMClaritas Pharmaceuticals, Inc. (CLAZF)finance.yahoo.com - January 12 at 4:39 PMOnline Pharmaceuticals Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Datamarketwatch.com - January 5 at 8:33 AMAnalgesics Market Global Investor, Latest Trends, Industry Growth, Size, Segmentation, Future Demands, by Regional Forecast to 2028marketwatch.com - November 30 at 7:14 AMPharmaceutical Sachet Market In 2022 : Industry Growth, Top Players, Segmentation and Forecast to 2028 with Top Countries Datamarketwatch.com - September 30 at 10:00 AMNew Claritas Report Reveals that the U.S. Hispanic Population Grew 89% Since 2000 – and Will Exceed 74 Million Consumers by 2028finance.yahoo.com - September 22 at 1:11 PMClaritas Pharmaceuticals Increuters.com - September 13 at 7:36 PMClaritas Pharmaceuticals Inc (CLAS)investing.com - May 11 at 10:49 AMKaya Now Appoints Stormy Simon As A Director Of The Boardbenzinga.com - March 12 at 6:52 PMClaritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financingfinance.yahoo.com - February 22 at 9:31 AMClaritas Anticipates Response from Australian Ethics Committee by February 18, 2022finance.yahoo.com - February 9 at 7:18 AMClaritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partnersfinance.yahoo.com - January 26 at 6:32 PMClaritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burnsfinance.yahoo.com - January 17 at 8:25 AMClaritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina Partnersfinance.yahoo.com - January 17 at 8:25 AMClaritas Pharmaceuticals signs $5M equity financing dealseekingalpha.com - January 12 at 3:32 PMClaritas Secures $5 Million Equity Financing Facility with Alumina Partners (Ontario) Ltd.finance.yahoo.com - January 12 at 3:32 PMClaritas to Develop R-107 for Treatment of PPHN, a Potentially Fatal Pulmonary Disorder in Newbornsfinance.yahoo.com - December 22 at 7:28 AMClaritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Diseasefinance.yahoo.com - December 21 at 9:43 AMClaritas Announces Publication of Peer-Reviewed Article Reporting that R-107 Significantly Improved Multi-Organ Function and Survival in an Ovine (Sheep) Model of Sepsisfinance.yahoo.com - December 20 at 8:54 AMClaritas Provides Update Regarding Phase 1 Clinical Studyfinance.yahoo.com - November 18 at 9:37 AMClaritas Announces Engagement of B. Riley Securities as Sponsor for the Company’s Planned Up-Listing of its Securities to the OTCQBfinance.yahoo.com - November 4 at 9:30 AMClaritas Announces Closing of Convertible Debenture Financing with Obsidian Global GP, LLCfinance.yahoo.com - October 19 at 8:57 AMCuraleaf Expands Edibles Portfolio With Select Snooze Bitesbenzinga.com - October 15 at 12:12 PMWhat Is Precision Psychiatry? Biotech Company Leverages New Approach To Mental Health Disordersbenzinga.com - October 13 at 12:00 AMMichigan Cannabis Sales Still Up There: September Earnings Reach $161.4Mbenzinga.com - October 13 at 12:00 AMClaritas Announces Option to Acquire Rights to Novel Drug for Treatment of COVID-19 Related ARDSfinance.yahoo.com - September 16 at 8:07 AMThe Bio Revolution of Medical Cannabinoid Therapeuticsbenzinga.com - September 13 at 9:24 PMNational Expungement Works Returns With Annual Weeklong Legal Relief Campaignbenzinga.com - September 9 at 4:33 AMHow Long Does Marijuana Stay In Your System?benzinga.com - September 5 at 8:47 PMClaritas Pharmaceuticals, Inc. (KALTD)au.finance.yahoo.com - August 20 at 6:11 PMClaritas Announces Grant of Stock Options to Directors and Officersfinance.yahoo.com - July 27 at 11:35 PMClaritas Cites Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with ...apnews.com - July 27 at 8:33 AMClaritas Cites Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe COVID-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107finance.yahoo.com - July 26 at 9:54 AM Get Claritas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KALTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Putin and other countries have a plan (Ad)Did you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy KALTF Media Mentions By Week KALTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KALTF News Sentiment▼0.000.46▲Average Medical News Sentiment KALTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KALTF Articles This Week▼00▲KALTF Articles Average Week Get Claritas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KALTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KALTF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Claritas Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
